Blood Group H Type 2

General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference

13 reference for EP0252

sort by year Reference detail
1 Chapman CM, Allhoff EP, Proppe KH, Prout GR Jr.
Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract.
J Histochem Cytochem. 1983 Apr ;31(4):557-61
PMID: 6827085
2 Clausen H, Levery SB, Nudelman E, Tsuchiya S, Hakomori S.
Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction.
Proc Natl Acad Sci U S A. 1985 Feb ;82(4):1199-203
PMID: 2579390
3 Yazawa S, Akamatsu S, Tachikawa T, Naito H, Nakamura J, Asao T, Nagamachi Y, Nakajima T, Shin S, Chia D.
Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer.
Jpn J Cancer Res. 1993 Jun ;84(6):641-8
PMID: 8340252
4 Naitoh H, Yazawa S, Asao T, Nakajima T, Nakamura J, Takenoshita S, Nagamachi Y.
The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2.
Surg Today. 1994 ;24(4):382-4
PMID: 8038519
5 Yazawa S, Nishimura T, Ide M, Asao T, Okamura A, Tanaka S, Takai I, Yagihashi Y, Saniabadi AR, Kochibe N.
Tumor-related expression of alpha1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for alpha1,2fucosyltransferase.
Glycobiology. 2002 Sep ;12(9):545-53
PMID: 12213787
6 Nakamura J, Yazawa S, Hada T, Asao T, Naitoh H, Takenoshita S, Kosaka M, Akamatsu S, Tachikawa T, Nagamachi Y.
The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma.
Glycoconj J. 1997 Jan ;14(1):81-7
PMID: 9076517
7 Nakajima T, Yazawa S, Miyazaki S, Furukawa K.
Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva.
J Immunol Methods. 1993 Feb 26;159(1-2):261-7
PMID: 8445257
8 Young WW Jr, Portoukalian J, Hakomori S.
Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain.
J Biol Chem. 1981 Nov 10;256(21):10967-72
PMID: 7287743
9 McGaughy J, Kaiser T, Sarter M.
Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density.
Behav Neurosci. 1996 Apr ;110(2):247-65
PMID: 8731052
10 Holmes EH, Hakomori S, Ostrander GK.
Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1----3N-acetylglucosaminyltransferase.
J Biol Chem. 1987 Nov 15;262(32):15649-58
PMID: 2960671
11 Kitamura K, Stockert E, Garin-Chesa P, Welt S, Lloyd KO, Armour KL, Wallace TP, Harris WJ, Carr FJ, Old LJ.
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12957-61
PMID: 7809154
12 Fredman P, Richert ND, Magnani JL, Willingham MC, Pastan I, Ginsburg V.
A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen.
J Biol Chem. 1983 Sep 25;258(18):11206-10
PMID: 6309836
13 Imai K, Sasanami T, Nakanishi T, Noguchi T, Yachi A.
Circulating blood group-related antigen(s) in cancer patients detected by the monoclonal antibodies produced against hepatocellular carcinoma cell line.
Tumour Biol. 1985 ;6(3):257-72
PMID: 2416034